1. Home
  2. ARDX vs OCSL Comparison

ARDX vs OCSL Comparison

Compare ARDX & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • OCSL
  • Stock Information
  • Founded
  • ARDX 2007
  • OCSL 2007
  • Country
  • ARDX United States
  • OCSL United States
  • Employees
  • ARDX N/A
  • OCSL N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • OCSL Finance: Consumer Services
  • Sector
  • ARDX Health Care
  • OCSL Finance
  • Exchange
  • ARDX Nasdaq
  • OCSL Nasdaq
  • Market Cap
  • ARDX 1.3B
  • OCSL 1.2B
  • IPO Year
  • ARDX 2014
  • OCSL 2008
  • Fundamental
  • Price
  • ARDX $3.39
  • OCSL $14.08
  • Analyst Decision
  • ARDX Strong Buy
  • OCSL Hold
  • Analyst Count
  • ARDX 8
  • OCSL 7
  • Target Price
  • ARDX $10.19
  • OCSL $16.00
  • AVG Volume (30 Days)
  • ARDX 6.4M
  • OCSL 713.6K
  • Earning Date
  • ARDX 05-01-2025
  • OCSL 05-01-2025
  • Dividend Yield
  • ARDX N/A
  • OCSL 14.01%
  • EPS Growth
  • ARDX N/A
  • OCSL N/A
  • EPS
  • ARDX N/A
  • OCSL 0.11
  • Revenue
  • ARDX $361,706,000.00
  • OCSL $353,866,000.00
  • Revenue This Year
  • ARDX $15.74
  • OCSL N/A
  • Revenue Next Year
  • ARDX $34.56
  • OCSL $1.34
  • P/E Ratio
  • ARDX N/A
  • OCSL $130.70
  • Revenue Growth
  • ARDX 127.33
  • OCSL N/A
  • 52 Week Low
  • ARDX $3.62
  • OCSL $12.50
  • 52 Week High
  • ARDX $9.20
  • OCSL $19.80
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 28.22
  • OCSL 50.74
  • Support Level
  • ARDX $3.50
  • OCSL $13.26
  • Resistance Level
  • ARDX $3.72
  • OCSL $14.40
  • Average True Range (ATR)
  • ARDX 0.26
  • OCSL 0.31
  • MACD
  • ARDX -0.13
  • OCSL 0.09
  • Stochastic Oscillator
  • ARDX 0.63
  • OCSL 60.51

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

Share on Social Networks: